|Bid||7.37 x 800|
|Ask||7.58 x 1400|
|Day's Range||7.36 - 7.82|
|52 Week Range||3.48 - 35.94|
|Beta (5Y Monthly)||2.27|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 02, 2022 - Nov 07, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||16.88|
Subscribe to Yahoo Finance Plus to view Fair Value for TGTX
The mean of analysts' price targets for TG Therapeutics (TGTX) points to a 192.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
This month, we saw the TG Therapeutics, Inc. ( NASDAQ:TGTX ) up an impressive 53%. But that doesn't change the fact...
TG Therapeutics (TGTX) delivered earnings and revenue surprises of 38.78% and 590.70%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?